Infinimmune
San Francisco
About Infinimmune
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: Seed
- Last round: Seed (Dec 2022)
- Website: infinimmune.com
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/infinimmune-35678 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.